FR2830016B1 - Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau - Google Patents

Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau

Info

Publication number
FR2830016B1
FR2830016B1 FR0112441A FR0112441A FR2830016B1 FR 2830016 B1 FR2830016 B1 FR 2830016B1 FR 0112441 A FR0112441 A FR 0112441A FR 0112441 A FR0112441 A FR 0112441A FR 2830016 B1 FR2830016 B1 FR 2830016B1
Authority
FR
France
Prior art keywords
cancers
vectorization
compositions
treatment
particularly brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0112441A
Other languages
English (en)
Other versions
FR2830016A1 (fr
Inventor
Jamal Temsamani
Anthony R Rees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synt EM SA
Original Assignee
Synt EM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synt EM SA filed Critical Synt EM SA
Priority to FR0112441A priority Critical patent/FR2830016B1/fr
Priority to US10/490,357 priority patent/US20060293242A1/en
Priority to PCT/FR2002/003290 priority patent/WO2003026701A1/fr
Priority to EP02799429A priority patent/EP1429810A1/fr
Publication of FR2830016A1 publication Critical patent/FR2830016A1/fr
Application granted granted Critical
Publication of FR2830016B1 publication Critical patent/FR2830016B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0112441A 2001-09-27 2001-09-27 Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau Expired - Fee Related FR2830016B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0112441A FR2830016B1 (fr) 2001-09-27 2001-09-27 Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau
US10/490,357 US20060293242A1 (en) 2001-09-27 2002-09-26 Transporting of taxoid derivatives through the blood brain barrier
PCT/FR2002/003290 WO2003026701A1 (fr) 2001-09-27 2002-09-26 Vectorisation de derives taxoides a travers la barriere hematoencephalique
EP02799429A EP1429810A1 (fr) 2001-09-27 2002-09-26 Vectorisation de derives taxoides a travers la barriere hematoencephalique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0112441A FR2830016B1 (fr) 2001-09-27 2001-09-27 Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau

Publications (2)

Publication Number Publication Date
FR2830016A1 FR2830016A1 (fr) 2003-03-28
FR2830016B1 true FR2830016B1 (fr) 2004-06-25

Family

ID=8867667

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0112441A Expired - Fee Related FR2830016B1 (fr) 2001-09-27 2001-09-27 Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau

Country Status (4)

Country Link
US (1) US20060293242A1 (fr)
EP (1) EP1429810A1 (fr)
FR (1) FR2830016B1 (fr)
WO (1) WO2003026701A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786398B1 (fr) 1998-11-30 2002-12-27 Synt Em Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide
WO2006049442A1 (fr) * 2004-11-03 2006-05-11 Forhumantech. Co., Ltd. Compositions pharmaceutiques destinees a etre administrees par voie transdermique
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
FR2968662B1 (fr) 2010-12-10 2013-11-22 Roussy Inst Gustave Nouveaux derives d'oxazaphosphorines pre-activees, utilisation et methode de preparation
EP3634978A1 (fr) 2017-06-07 2020-04-15 Adrx, Inc. Inhibiteur d'agrégation de tau
CA3073062A1 (fr) 2017-08-18 2019-02-21 Adrx, Inc. Inhibiteurs peptidiques d'agregation de tau

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
FR2786398B1 (fr) * 1998-11-30 2002-12-27 Synt Em Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide
FR2786397B1 (fr) * 1998-11-30 2003-01-10 Synt Em Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc
FR2810985B1 (fr) * 2000-07-03 2004-12-24 Synt Em Peptides lineaires amphipathiques et les compositions les contenant
AU2001260526A1 (en) * 2001-05-07 2001-12-03 Supratek Pharma, Inc. A ligand for enhancing oral and cns delivery of biological agents

Also Published As

Publication number Publication date
EP1429810A1 (fr) 2004-06-23
WO2003026701A1 (fr) 2003-04-03
FR2830016A1 (fr) 2003-03-28
US20060293242A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
ATE250924T1 (de) Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel
HUP0301146A3 (en) 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
DE60112275D1 (de) Schmutzlösende polymere und diese enthaltende waschmittelzusammensetzungen
DE60113333D1 (de) Metall-Legierungs-Zusammensetzungen und damit verbundene Plattierungsmethode
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
ATE354570T1 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0104959A3 (en) Quinoline-4-carboxamide derivatives their preparation, their use as nk-3 and nk-2 receptor antagonists and medicaments containing them
ATE320256T1 (de) Succinate des 5,8,14-triazatetracyclo(10.3.1.0 2, 11 .0 4,9 )-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0101839A3 (en) Heterocyclically substituted amides with cysteine protease-inhibiting effect, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
FR2826579B1 (fr) Composition cosmetique contenant au moins une huile extraite de graines de cucurbitacees, son utilisation cosmetique, therapeutique et alimentaire
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
NO20030800D0 (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
YU13301A (sh) Muskarinski agonisti i antagonisti
ATE327978T1 (de) Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
DE60042585D1 (de) 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken
FR2830016B1 (fr) Compositions pour la vectorisation de derives taxoides a travers la barriere hematoencephalique et leur utilisation pour le traitement des cancers, plus particulierement des cancers du cerveau
TNSN03043A1 (en) 2h-1 benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
ATE337321T1 (de) Cabapenemderivate, ihre anwendung und ihre zwischenprodukte
ATE204266T1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140530